<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Drug Study - Torres, Alyson Getsie M. by Alyson Getsie Torres</title>
      <link>https://padlet.com/torresalysongetsie/puxtduoea62cih23</link>
      <description>Clopidogrel &amp; Digoxin</description>
      <language>en-us</language>
      <pubDate>2021-09-17 06:58:21 UTC</pubDate>
      <lastBuildDate>2024-05-28 17:23:01 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>Clopidogrel</title>
         <author>torresalysongetsie</author>
         <link>https://padlet.com/torresalysongetsie/puxtduoea62cih23/wish/1748039377</link>
         <description><![CDATA[<ul><li>Generic Name: clopidogrel</li></ul><div><br></div><ul><li>Brand Name: Apo-Clopidogrel</li></ul><div><br></div><ul><li>Stock Dosage:</li></ul><div>Tablets: 75 mg, 300 mg; PO (avoid grapefruit products)</div><div><br></div><ul><li>Classification:</li><li>Pharmacotherapeutic: Thienopyridine derivative</li><li>Clinical: Antiplatelet</li></ul><div><br></div><ul><li>Mechanism of Action:</li></ul><div>This drug inhibits the binding of enzyme adenosine phosphate (ADP) to its platelet receptor and subsequent ADP-mediated activation of glycoprotein complex with a a therapeutic effect: inhibits platelet aggregation</div><div><br><br></div><ul><li>Indication/s:</li></ul><div>To decrease rate of Myocardial Infarction and stroke in patients with non-ST segment elevation acute coronary syndrome (ACS), acute ST-elevation MI(STEMI), patients with history of recent Myocardial Infarction or stroke, established peripheral arterial disease (PAD)&nbsp;<br><br></div><div>- Recent MI, Stroke, PAD</div><div>PO: Adults, Elderly = 75 mg once a day<br><br></div><div>- Unstable Angina/NSTEMI</div><div>PO: Adults, Elderly(&lt;75 y/o) = loading dose 300-600 mg, then 75 mg once a day in combination with aspirin for up to 12 months while indefinitely for aspirin)</div><div><br><br></div><ul><li>Contraindications:</li></ul><div>Contraindicated to patients with hypersensitivity to clopidogrel and active bleeding</div><div><br><br></div><ul><li>Side Effects and Adverse Effects:</li></ul><div>- Frequent side effects (15%): Skin disorders</div><div>- Occasional side effects (8-6%): UTI, chest pain, flu-like symptoms, headache, dizziness, arthralgia</div><div>- Rare Effects (5-3%): Fatigue, edema, hypertension</div><div><br></div><ul><li>Nursing Responsibilities</li></ul><div>- Conduct baseline assessment: platelet count<br>- Monitor platelet count for evidence of thrombocytopenia<br>- Assess Hgb, Hct<br>- Report any unusual bleeding<br><br><br>Source:&nbsp;</div><div><br></div><div>Hodgson, B., &amp; Kizior, R. (2019). Saunders Nursing Drug Handbook 2019. St. Louis: Elsevier.</div><div><br></div>]]></description>
         <enclosure url="http://www.allivet.com/images/product/large/7777.jpg" />
         <pubDate>2021-09-17 07:03:28 UTC</pubDate>
         <guid>https://padlet.com/torresalysongetsie/puxtduoea62cih23/wish/1748039377</guid>
      </item>
      <item>
         <title>Digoxin</title>
         <author>torresalysongetsie</author>
         <link>https://padlet.com/torresalysongetsie/puxtduoea62cih23/wish/1748041933</link>
         <description><![CDATA[<ul><li>Generic Name: digoxin</li></ul><div><br></div><ul><li>Brand Name: Lanoxin</li></ul><div><br></div><ul><li>Stock Dosage:&nbsp;</li></ul><div>- Oral Solution (Lanoxin): 50 mcg/mL<br>- Injection Solution (Lanoxin): 100 mcg/mL, 250 mcg/mL<br>- Tablets (Lanoxin): 62.5 mcg, 125 mcg, 187.5 mcg, 250 mcg</div><div><br></div><ul><li>Classification:</li></ul><div>- Pharmacotherapeutic: Cardiac glycoside<br>- Clinical: Antiarrhythmic, cardiotonic</div><div><br></div><ul><li>Mechanism of Action:</li></ul><div>Heart failure: Inhibits sodium/potassium ATPase pump in myocardial cells. Promotes calcium influx</div><div>Supraventricular Arrhythmias: Suppresses AV node conduction</div><div><br></div><ul><li>Indication/s:</li></ul><div>Treatment of mild to moderate heart failure. Control ventricular response rate in patients with chronic atrial fibrillation&nbsp;</div><div><br></div><ul><li>Contraindications:</li></ul><div>Contraindicated to patients with hypersensitivity to digoxin&nbsp;</div><div><br></div><ul><li>Side Effects and Adverse Effects:</li></ul><div>Dizziness, headache, diarrhea, rash, visual disturbances</div><div><br></div><ul><li>Nursing Responsibilities:</li></ul><div>- Assess apical pulse, if it is 60 or less/min withhold drug and contact physician<br>- Monitor pulse for bradycardia, EKG for arrhythmias for 1-2 hours after administration&nbsp;<br>- Do not increase or skip doses</div><div><br></div><div>Source:&nbsp;</div><div><br></div><div>Hodgson, B., &amp; Kizior, R. (2019). Saunders Nursing Drug Handbook 2019. St. Louis: Elsevier.</div><div><br><br></div><div><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1351756820/9ecc50ea6d5de2eac792a1430aefb1dc/digoxin.jfif" />
         <pubDate>2021-09-17 07:05:10 UTC</pubDate>
         <guid>https://padlet.com/torresalysongetsie/puxtduoea62cih23/wish/1748041933</guid>
      </item>
   </channel>
</rss>
